Peking University, June 11, 2011: The kick-off meeting of the cooperating project on medical development between Peking University Health Science Center (PUHSC) and Bayer Healthcare Company Ltd. was held on the morning of June 9.

Professor Ke Yang, executive vice president of Peking University (PKU) and executive vice president of PUHSC, addressed a speech in the meeting. She mentioned that Bayer Healthcare could offer PUHSC supports to enforce the reformation on combining practice with theory, explore effective ways of co-coordinating education, form a stable joint training system which  would form a win-win situation for both the company and students, and establish boarder platform for theoretical knowledge and practical skills.

Li Xilie, president of Bayer Healthcare in China, looked forward to a deeper cooperation between Bayer and PKU in medical innovation, and find ways to promote the cooperation between business and universities. He said that Bayer and PKU were shouldering the mission to promote the medical research and development, which would have long and profound effect on enhancing the quality of pharmaceuticals and improving the Chinese people’s standards of health security.

Professor Hu Yonghua, executive deputy dean of PKU School of Public Health, introduced the background and details of this cooperating project. He said that School of Public Health had cooperation with Bayer in lectures, data analysis, and clinical research in recent years. In 2010, the specialists from Bayer lectured at School of Public Health, receiving good comments from students. Nowadays, both sides get a conclusion that researches and cooperation in the field of medical development and clinical practical management have significant importance in enhancing the quality of pharmaceuticals and improving the standard of health security. Besides the research field, Bayer Healthcare also cooperates with PKU in talents training through providing financial support, establishing scholarship, and offering internship for students. 

Professor Ke Yang and President Li Yilie signed on the memo. Following the signing ceremony were academic reports addressed by specialists from Bayer and PKU to introduce specific contacts of this project.

Background Info:
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition, and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 16.913 billion (2010), is one of the world’s leading and innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare’s aim is to discover and manufacture products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,700 employees (Dec. 31, 2010) and is represented in more than 100 countries.

Written by: Jiang Zhaohui
Edited by: Su Juan
Source: PKU News (Chinese)